29,561 Shares in Oscar Health, Inc. (NYSE:OSCR) Purchased by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC acquired a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 29,561 shares of the company’s stock, valued at approximately $627,000.

A number of other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in shares of Oscar Health by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after purchasing an additional 337,850 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after buying an additional 2,409,160 shares during the period. Renaissance Technologies LLC raised its position in shares of Oscar Health by 31.7% during the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after acquiring an additional 934,600 shares during the last quarter. First Light Asset Management LLC lifted its stake in shares of Oscar Health by 117.3% during the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock valued at $31,265,000 after acquiring an additional 1,134,919 shares during the period. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Oscar Health by 32.9% during the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after acquiring an additional 507,009 shares during the period. 75.70% of the stock is owned by institutional investors.

Analyst Ratings Changes

OSCR has been the subject of several analyst reports. Piper Sandler reiterated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, UBS Group initiated coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.93.

Insider Activity at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at approximately $2,530,257.52. This trade represents a 2.92 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $286,488.58. Following the sale, the executive vice president now directly owns 392,607 shares of the company’s stock, valued at $6,697,875.42. This represents a 4.10 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 169,569 shares worth $3,007,069. 25.11% of the stock is owned by insiders.

Oscar Health Trading Down 3.7 %

Shares of NYSE OSCR opened at $14.87 on Friday. Oscar Health, Inc. has a twelve month low of $6.93 and a twelve month high of $23.79. The stock has a market cap of $3.60 billion, a price-to-earnings ratio of -247.83 and a beta of 1.67. The company has a quick ratio of 0.91, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company’s fifty day moving average is $18.20 and its 200-day moving average is $18.27.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the prior year, the firm posted ($0.29) earnings per share. The business’s revenue was up 68.3% on a year-over-year basis. Equities research analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.